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Silent Sinus Syndrome: An Uncommon Cause of Diplopia
Abstract
Background: Silent sinus syndrome is a rare condition with multiple ophthalmic findings of significance.
Chronic, subclinical maxillary sinus inflammation alters the pressure gradient, leading to eventual
maxillary sinus collapse, orbital floor depression, enophthalmos, and diplopia.
Case Report: Functional endoscopic sinus surgery may be indicated to correct diplopia and/or cosmesis.
Conclusion: Patients unbothered by facial asymmetry may be managed with prism in eyeglasses.
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INTRODUCTION
Silent sinus syndrome (SSS) is a rare condition with multiple ophthalmic findings of
significance. Chronic, subclinical inflammation and subsequent altered pressure gradient
of the maxillary sinus leads to its eventual collapse. The resulting depression of the orbital
floor often leads to hypoglobus and enophthalmos. Radiologic imaging is critical for
diagnosis.1 It should be noted that ‘silent’ refers to absence of sinusitis symptoms rather
than ocular symptoms.2
CASE REPORT
A 67-year-old white male presented with chief complaint of painless, constant vertical
diplopia in primary gaze that had been present for six to eight months. He had no history
of trauma and did not complain of headache, fever, malaise, jaw claudication, or scalp
tenderness. He underwent cataract surgery with posterior chamber intraocular lens
implantation in both eyes five years prior. He was prescribed atorvastatin calcium 20 mg
daily for cholesterol, 8 units aspart insulin three times daily and 500 mg metformin HCl
twice daily for type 2 diabetes, levothyroxine sodium 0.05 mg daily for hypothyroidism,
sildenafil citrate 100 mg daily for erectile dysfunction, and warfarin sodium 5 mg three
times daily for history of venous thrombosis.
Best corrected vision measured 20/20 in the right and left eyes. Pupils were equal, round,
and reactive to light without afferent defect. Confrontation visual fields were full.
Extraocular motility was intact. He demonstrated 12 prism diopters of left hypertropia and
2 prism diopters of exophoria at distance. There was 4 mm of right hypoglobus (Figure 1)
without ptosis. Exophthalmometry was 21 mm in both eyes.

Figure 1: Right hypoglobus measuring 4 mm

Intraocular pressure measured 16 mmHg in the right and left eyes. Both eyes had mild
corneal gutatta, clear posterior chamber intraocular lenses, 0.25 cup-to-disc ratio without

Published by The Athenaeum,

Optometric Clinical Practice, Vol. 2 [], Iss. 1, Art. 3

edema, flat and intact maculae and peripheral retinas without choroidal folds. Optical
coherence tomography showed normal foveal contour without sub- or intra-retinal fluid.
Vasculopathic etiology of diplopia was ruled out as resolution would be expected within
three months3 and this patient’s symptoms were present for at least six months. Statins have
been associated with the precipitation of myasthenia gravis,4,5 however there was no
fluctuation in symptoms, particularly at the end of the day.3,5 Inflammatory etiology (such
as thyroid eye disease or giant cell arteritis) was considered, however hypoglobus is
unexpected in both conditions; headache, fever, malaise, jaw claudication, and scalp
tenderness were absent.3 The patient was being treated medically for subclinical
hypothyroidism for 2 years and had normal TSH levels 2 months prior. Pupil symmetry
and lack of ptosis ruled out cranial nerve III palsy and Horner’s syndrome.3,5 He had no
history of trauma.

Figure 2 (left):
Before onset of
diplopia, MRI with
contrast revealed
diminutive right
maxillary sinus and
chronic right
maxillary sinus
disease.
Figure 3 (right):
MRI with contrast
through right orbit
and maxillary sinus.

Several months prior to the onset of diplopia, the patient’s primary care provider ordered
contrasted magnetic resonance imaging (MRI) of the brain because of ataxia. An incidental
finding of right maxillary sinus disease (Figures 2 and 3) without hypoglobus was revealed.
New diplopia with hypoglobus prompted ordering of comparison contrasted MRI of the
face and orbits, which demonstrated interval change with decreased right maxillary sinus
size, depression of the right orbital floor and confirmed lower globe position, suggesting
silent sinus syndrome (Figures 4 and 5).
The patient’s diplopia was relieved with eyeglasses having 7 diopters base up prism in
the right eye. He was unbothered by facial asymmetry and declined consultation with
oculoplastics for surgical correction.
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Figure 4 (left):
MRI with contrast
after onset of
diplopia
demonstrating right
orbital floor
depression and
hypoglobus.
Figure 5 (right):
MRI with contrast
through right orbit
and maxillary sinus.

DISCUSSION
Silent sinus syndrome was first described by Montgomery in 1964 but not named until
1994 by Soparkar and colleagues.1,6,7 It consists of asymptomatic maxillary sinus
hypoplasia that leads to abnormalities of the ipsilateral orbital floor. These abnormalities
usually manifest as bone resorption and remodeling which leads to spontaneous
enophthalmos and/or hypoglobus.6,8
Chronic maxillary atelectasis (CMA) represents a spectrum of maxillary sinus disease
that in its late stages can manifest as SSS. In CMA and SSS, symptoms are inversely related
to anatomical changes; that is, those who are asymptomatic have greater sinus changes
apparent on radiologic imaging.9 Symptoms of sinus disease may or may not be present in
CMA, and patients are more likely to be asymptomatic when more advanced disease (such
as SSS) is present.8,9 Soparkar’s diagnostic criteria for SSS include modification of facial
appearance, hypoglobus and/or enophthalmos, decreased maxillary sinus volume on
radiologic imaging, and the lack of sinus-related symptoms.6
Although SSS is a late-stage manifestation of CMA, no extensive studies on the incidence
of SSS exist, possibly due to the rare nature of the condition. Depending on the literature
source, there is wide variability in diagnostic nomenclature between CMA and SSS, with
the term “CMA” more commonly used in otolaryngology literature and “SSS” favored in
ophthalmology literature.9 For example, Numa and colleagues1 reviewed all 84 reported
cases of SSS in 2005. Three years later, Brandt and colleagues9 determined that 32 out of
the 62 journal articles they identified met their review criteria; of those, only 55 cases of
SSS met what they defined as a complete data set and of those, only 28 cases met the
diagnostic criteria for SSS. Using this methodology, they determined that 85% of SSS met
diagnostic criteria for CMA and proposed abandoning the term SSS in favor of CMA, as
both seem to be on a spectrum of the same clinical entity, with SSS being a late-stage
manifestation of CMA.
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The development of SSS is brought on by a buildup of negative pressure within the
maxillary sinus. The ostiomeatal complex is the opening between the maxillary sinus and
the surrounding tissues. A flap-valve effect of the uncinate process incites a blockage of
the ostiomeatal complex. Gas resorption into the capillaries leads to negative pressure build
up and an accumulation of inflammatory secretions within the maxillary sinus. Inward
bowing of the sinus wall leads to bone resorption and remodeling of the orbital floor. This
negative pressure and inward bowing of the sinus wall can lead to depression of the orbital
floor, the weakest wall of the maxillary sinus. The resultant change in orbital anatomy
causes hypoglobus and/or enophthalmos.1,9,10
Patients with SSS may present with one or more ophthalmic findings of significance.
Findings most likely to be found on clinical examination include enophthalmos (98100%)1,9 and hypoglobus (44-53%),9 measuring on average 2.96 mm and 2.78 mm
respectively.11 Although extraocular motility remains normal in a majority of cases,9,12
there are reported cases of altered superior and inferior oblique muscle action due to a
relative dislocation between the extraocular muscle insertion points at the globe and the
muscle origins on the orbit.1 Other findings include diplopia (28-65%)1,9 and history of
sinus disease (56%).7 Measurements of lid abnormality can also aid in evaluation and
diagnosis. Enophthalmos can lead to a decreased palpebral fissure. Hypoglobus can lead
to an increased margin crease distance and exposure-related dryness. Leading chief
complaint is facial asymmetry (69%) followed by diplopia (65%).9 Mean symptom
duration is 6.5 months.1 Right- and left-sided disease incidence is equal and there is no
gender predilection.9 Visual acuity usually remains intact.9
Radiologic imaging is essential for diagnosis, and CT and MRI are both acceptable
imaging modalities.12 In a 2008 review of cases by Brandt and Wright, maxillary sinus
contraction was seen in 100% of patients.9 The next most common radiologic findings
include: orbital floor depression (87%), opacification of the sinus (84%), other sinus
disease (61%), and inward bowing of maxillary walls (47%).9 Given that there is a lack of
sinus symptoms in patients diagnosed with SSS, surgical intervention may not always be
indicated. Prism correction of diplopia may be sufficient in patients who are unconcerned
with cosmesis. It should be noted that vertical strabismus measurement in prism diopters
is independent of hypoglobus measurement in millimeters. Cover test with prism
neutralization or other binocular vision tests should be done in addition to measuring
hypoglobus using the corneal light reflex. If the Hirschberg reflex is used to aid in
determining prescribed prism, the distance between the reflex in strabismic posture and the
visual axis should be used; this is separate from the measurement of hypoglobus using the
corneal light reflex. In patients motivated to restore normal facial appearance or improve
diplopia without optical correction, surgical intervention is necessary.
Surgical approaches are separated into sinonasal and orbital. Functional endoscopic sinus
surgery (FESS) is the gold standard sinonasal approach.9 The main objectives of FESS are
to restore drainage of the maxillary sinus (which will prevent future sinus disease), and
decrease enophthalmos and/or hypoglobus (indirectly restoring orbital anatomy).13 FESS
begins with a septoplasty to allow access to the maxillary sinus. An uncinectomy may be
performed to re-establish drainage through the osteomeatal complex. An antrostomy
enlarges the maxillary sinus ostium. These steps alone may re-establish sinus ventilation
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and allow for the orbital floor to rise to its normal position,9 effectively avoiding orbital
surgery. It is hypothesized that surgical correction of the maxillary sinus can indirectly
improve hypoglobus and enophthalmos due to poorly understood alterations that occur in
the maxillary sinus after surgery.11 However, some surgeons prefer to complete orbital
floor reconstruction immediately following FESS. Concomitant orbital floor repair avoids
a second operation and anesthesia administration yet is more invasive, increases surgical
time, and leads to an identical outcome in many patients.1,2,11,13
CONCLUSION
Although infrequently encountered, silent sinus syndrome represents a condition that is
likely to first present to an eye care provider. This case report demonstrates the importance
of understanding differential diagnoses of diplopia. The natural history of silent sinus
syndrome is evidenced by interval change demonstrated by MRI. The eye care provider
should aim for a team approach with radiologic, otolaryngology, and oculoplastic services
for both diagnosis and management of this unusual condition.
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